(Q42609366)

3 November 2017

Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial (English)

1 reference

3 November 2017

1 reference

Medina MT

1

1 reference

3 November 2017

Genton P

2

1 reference

3 November 2017

Montoya MC

3

1 reference

3 November 2017

Córdova S

4

1 reference

3 November 2017

Dravet C

5

1 reference

3 November 2017

Sotelo J

6

1 reference

3 November 2017

1 November 1993

1 reference

3 November 2017

1 reference

3 November 2017

34

1 reference

3 November 2017

6

1 reference

3 November 2017

1024-1027

1 reference

Neurocysticercosis. Short course of treatment with albendazole

3 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02128.X

Antihelminthic therapy for neurocysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02128.X

Neurocysticercosis as the main cause of late-onset epilepsy in Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02128.X

Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02128.X

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB02128.X

10.1111/J.1528-1157.1993.TB02128.X

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference